Skip to main navigation Skip to search Skip to main content

Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease

  • Margaux F. Keller
  • , Mohamad Saad
  • , Jose Bras
  • , Francesco Bettella
  • , Nayia Nicolaou
  • , Javier Simón-Sánchez
  • , Florian Mittag
  • , Finja Büchel
  • , Manu Sharma
  • , J. Raphael Gibbs
  • , Claudia Schulte
  • , Valentina Moskvina
  • , Alexandra Durr
  • , Peter Holmans
  • , Laura L. Kilarski
  • , Rita Guerreiro
  • , Dena G. Hernandez
  • , Alexis Brice
  • , Pauli Ylikotila
  • , Hreinn Stefánsson
  • Kari Majamaa, Huw R. Morris, Nigel Williams, Thomas Gasser, Peter Heutink, Nicholas W. Wood, John Hardy, Maria Martinez, Andrew B. Singleton, Michael A. Nalls*, Vincent Plagnol, Una Marie Sheerin, Suzanne Lesage, Sigurlaug Sveinbjörnsdóttir, Sampath Arepalli, Roger Barker, Yoav Ben-Shlomo, Henk W. Berendse, Daniela Berg, Kailash Bhatia, Rob M.A. de Bie, Alessandro Biffi, Bas Bloem, Zoltan Bochdanovits, Michael Bonin, Kathrin Brockmann, Janet Brooks, David J. Burn, Gavin Charlesworth, Honglei Chen, Patrick F. Chinnery, Sean Chong, Carl E. Clarke, Mark R. Cookson, J. Mark Cooper, Jean Christophe Corvol, Carl Counsell, Philippe Damier, Jean François Dartigues, Panos Deloukas, Günther Deuschl, David T. Dexter, Karin D. van Dijk, Allissa Dillman, Frank Durif, Alexandra Dürr, Sarah Edkins, Jonathan R. Evans, Thomas Foltynie, Jianjun Gao, Michelle Gardner, Alison Goate, Emma Gray, Ómar Gústafsson, Clare Harris, Jacobus J. van Hilten, Albert Hofman, Albert Hollenbeck, Janice Holton, Michele Hu, Xuemei Huang, Heiko Huber, Gavin Hudson, Sarah E. Hunt, Johanna Huttenlocher, Thomas Illig, Pálmi V. Jónsson, Jean Charles Lambert, Cordelia Langford, Andrew Lees, Peter Lichtner, Patricia Limousin, Grisel Lopez, Delia Lorenz, Alisdair McNeill, Catriona Moorby, Matthew Moore, Karen E. Morrison, Ese Mudanohwo, Sean S. O'Sullivan, Justin Pearson, Joel S. Perlmutter, Hjörvar Pétursson, Pierre Pollak, Bart Post, Simon C. Potter, Bernard Ravina, Tamas Revesz, Olaf Riess, Fernando Rivadeneira, Patrizia Rizzu, Mina Ryten, Stephen J. Sawcer, Anthony Schapira, Hans Scheffer, Karen Shaw, Ira Shoulson, Ellen Sidransky, Colin Smith, Chris C.A. Spencer, Stacy Steinberg, Joanna D. Stockton, Amy Strange, Kevin Talbot, Carlie M. Tanner, Avazeh Tashakkori-Ghanbaria, François Tison, Daniah Trabzuni, Bryan J. Traynor, André G. Uitterlinden, Daan Velseboer, Marie Vidailhet, Robert Walker, Bart van de Warrenburg, Mirdhu Wickremaratchi, Caroline H. Williams-Gray, Sophie Winder-Rhodes, Kári Stefánsson, Peter Donnelly, Ines Barroso, Jenefer M. Blackwell, Elvira Bramon, Matthew A. Brown, Juan P. Casas, Aiden Corvin, Audrey Duncanson, Janusz Jankowski, Hugh S. Markus, Christopher G. Mathew, Colin N.A. Palmer, Robert Plomin, Anna Rautanen, Richard C. Trembath, Ananth C. Viswanathan, Gavin Band, Céline Bellenguez, Colin Freeman, Garrett Hellenthal, Eleni Giannoulatou, Matti Pirinen, Richard Pearson, Zhan Su, Damjan Vukcevic, Rhian Gwilliam, Hannah Blackburn, Suzannah J. Bumpstead, Serge Dronov, Matthew Gillman, Naomi Hammond, Alagurevathi Jayakumar, Owen T. McCann, Jennifer Liddle, Radhi Ravindrarajah, Michelle Ricketts, Matthew Waller, Paul Weston, Sara Widaa, Pamela Whittaker, Mark I. McCarthy
*Corresponding author for this work
  • National Institutes of Health
  • Temple University
  • Institut national de la santé et de la recherche médicale
  • INSERM UMR 1043 and Paul Sabatier University
  • University College London
  • deCODE Genetics
  • VU University Medical Center
  • University of Tübingen
  • German Center for Neurodegenerative Diseases
  • Cardiff University
  • Sorbonne Université
  • Assistance publique – Hôpitaux de Paris
  • CNRS
  • UMR-S975
  • University of Turku
  • University of Oulu
  • Landspitali University Hospital
  • Mid and South Essex NHS Foundation Trust
  • Queen Mary University of London
  • University of Cambridge
  • University of Bristol
  • University of Amsterdam
  • Massachusetts General Hospital
  • Broad Institute
  • Radboud University Nijmegen
  • Newcastle University
  • University of Birmingham
  • Sandwell and West Birmingham Hospitals NHS Trust
  • University of Aberdeen
  • Department of Neurology
  • Wellcome Trust
  • Kiel University
  • Imperial College London
  • Hôpital Gabriel Montpied
  • Washington University St. Louis
  • University of Oslo
  • Leiden University
  • Erasmus University Rotterdam
  • AARP
  • John Radcliffe Hospital
  • Pennsylvania State University
  • Helmholtz Zentrum München - German Research Center for Environmental Health
  • Université de Lille
  • University Hospitals Birmingham NHS Foundation Trust
  • National Hospital for Neurology and Neurosurgery
  • CHU de Grenoble
  • Biogen IDEC
  • University of Rochester
  • University of Edinburgh
  • University of Oxford
  • Parkinson's Institute
  • Hopital Haut-Leveque
  • Telethon Kids Institute
  • King's College London
  • University of Queensland
  • London School of Hygiene and Tropical Medicine
  • Trinity College Dublin
  • Leicester Royal Infirmary
  • St. George's University of London
  • Guy's and St Thomas' NHS Foundation Trust
  • University of Dundee
  • Moorfields Eye Hospital NHS Foundation Trust
  • Oxford University Hospitals NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

Abstract

Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.

Original languageEnglish
Pages (from-to)4996-5009
Number of pages14
JournalHuman Molecular Genetics
Volume21
Issue number22
DOIs
Publication statusPublished - Nov 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease'. Together they form a unique fingerprint.

Cite this